Triple-Hormone Agonist Peptides for Weight Loss
LiveNow Longevity
Retatrutide is an investigational GLP-1, GIP and glucagon receptor agonist. It is not FDA-approved. FDA explicitly states that retatrutide cannot be used in compounding under federal law. This article provides research and regulatory information; it does not offer treatment, a waitlist or access through a clinic evaluation.
What does the research show?
The 2023 phase 2 randomized trial enrolled 338 adults and studied weight change and adverse events. Results from that research population do not establish an individual outcome, routine prescribing eligibility or regulatory approval. The trial reported gastrointestinal adverse events and increases in heart rate. More receptor targets do not by themselves establish superiority over another treatment.
Can retatrutide be compounded or obtained after an evaluation?
No. FDA states that retatrutide cannot be compounded under federal law. Physician supervision, a supplier certificate or state rules do not establish an exception. An evaluation at LiveNow is not a route to obtaining retatrutide. Any investigational access must follow the applicable authorized study or regulatory pathway; this article does not arrange it.
Approved weight-management options are a separate decision
Patients seeking care now can discuss FDA-approved weight-management options with their treating clinician. The exact approved product, indication, contraindications, costs and follow-up matter. An approved ingredient does not make a compounded preparation FDA-approved. No prescription, change in medication or outcome is promised here.
Key takeaways
- Retatrutide remains investigational and is not FDA-approved.
- FDA prohibits its use in compounding under federal law.
- This article does not sell or arrange retatrutide treatment.
- A clinical trial result is not an individual treatment recommendation or an approval date.
Common questions
Is retatrutide available in Las Vegas right now?
It is not an FDA-approved prescription option, and FDA says it cannot be compounded under federal law. LiveNow does not offer access through this article or a general evaluation.
What does retatrutide treatment cost?
There is no retatrutide treatment price or sales offer on this article. A general medical evaluation and any approved treatment are separate services with their own costs.
When will retatrutide be approved?
No approval date is promised here. Follow FDA for regulatory status and the relevant study team for research eligibility and oversight.
Read the FDA source and the original study below. For related educational information, see the retatrutide FDA-status guide. Do not change an existing medication based on research headlines; discuss individual care with your prescriber.